
Stem cells derived from heart failure patients’ own bone marrow and injected into their hearts improved the function of the left ventricle, the heart’s pumping chamber. Mayo Clinic researchers also found that certain types of the stem cells were associated with the largest improvement and needs further study.
These results were presented today at the 2012 American College of Cardiology Meeting in Chicago. They will also be published online in the Journal of the American Medical Association.
Soundbites from Mayo Clinic cardiologist, Dr. Robert Simari, and Dr. Emerson Perin of the Texas Heart Institute, as well as broll of Dr. Perin's news conference at ACC are in the downloads above
Dr. Robert Simari is also chairman of the Cardiovascular Cell Therapy Research Network (CCTRN), the network of five academic centers and associated satellite sites that conducted the study.
Expert Title: Dr. Robert Simari, Mayo Clinic Cardiologist
Expert Title: Dr. Emerson Perin, Texas Heart Institute
Click HERE for entire news release
Follow latest ACC news on Twitter: #ACC12 #mayoclinic @FarrisTimimi
stem cells derived from heart failure patients’ own bone marrow and injected into their hearts improved the function of the left ventricle, the heart’s pumping chamber.
National Wear Red Day is an annual event held each first Friday of February, dedicated to raising awareness about heart disease in women. It's the ...
Congenital heart disease is the most commonly diagnosed disorder in newborns worldwide. While babies born with this condition are living longer and healthier lives, some ...
EAU CLAIRE, Wis. — When it comes to exercise, what's best for your heart: slow and steady, or fast and furious? How about a combination of ...